Searched for
CIPLA EARNINGS PREVIEW
Cipla Q1 results preview: Muted US sales to hit revenue YoY. 4 things to watch out forCipla's June quarter earnings are anticipated to reveal a mixed performance, with robust India sales partially offsetting challenges in the...- Cipla Q3 preview: Up to 7% YoY uptick seen in revenue. Margins to fall on a YoY and sequential basisCipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth. Brokerages have differi...
- Cipla Q1 results preview: PAT may grow 6.5-14% YoY, up to 10% growth seen in revenueCipla reported Q1FY25 net profit expected between Rs 1,061-1,135 crore, with YoY growth of 6.5%-14%. Revenue estimated at Rs 6,749-6,879 cr...
- Stocks with good short-term prospects likely to manage volatility; 5 stocks with up to 32% upsideStocks with good short-term prospects are more likely to manage volatility, which is expected to intensify amid multiple geopolitical and m...
- 7 Nifty50 companies to post Q1 results on Wednesday. Here's what to expectBajaj Finance is expected to post a good set of numbers in Q1FY24
- Q4 results today: What's in store for Tata Motors, DLF, Vedanta and Cipla?Tata Motors is expected to report a net profit of between INR 3,100 to 3,204 crore and revenue growth of up to 34% for Q4 on the back of st...
- HDFC, Cipla, Sun Pharma to report Q1 results today. Here's what to expectOut of the 27 Nifty50 companies that have reported their quarterly numbers so far, 12 have reported results that beat Street expectations, ...
- Wondering what this earnings season has in store? Check out brokers’ sector-wise previewMargins remained pressured as companies deal with elevated attrition resulting in high retention costs and increase in travel and discretio...
- Cipla Q4 results preview: Here's what analysts sayPhillip Capital expects 8.1 per cent YoY growth in net profit of Cipla.
- Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
- Cipla shares flat ahead of Q3 results: What to expectNirmal Bang Securities sees 12.70 per cent year-on-year rise in net profit for Cipla in Q3 FY19 on 7 per cent.
- Cipla, GAIL, Power Grid, SBI Q2 results today; what to look forBrokerage firm Sharekhan expects domestic loan growth of SBI to improve.
- Stocks in focus on May 22, 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
- Pharma is far from feeling healthy, GST adds to painThe GST rollout has impacted the primary sales of pharma companies in the domestic market and aggravated their overall performance.
- Bullish on selective midcap names: Gaurang Shah, Geojit BNP ParibasThe biggest play is going to be over a longer period of time all those Indian corporates who have ventured into the defence after the polic...
- Q3 earnings: India Inc likely to report 12.2% rise in net profit in December quarterThe companies in the 50-share Nifty index may report a 17.6% year-on-year growth in operating profit for the third quarter - the best in si...
- Cipla expected to report 34% gain in Q4 net profitCIPLA is expected to report a 34% YoY increase in its Q4 net profit at Rs 286 crore compared to Rs 214 crore in the year ago period, accord...
- Pharma valuations will suffer due to over charging controversy: Bharti AXAET NOW Fundamental Check with Prateek Agarwal, Head Equities, Bharti AXA Invest Manager
- Pharma hopes to reap from new acquisitions, local salesPharmaceutical companies are seen posting a 40-50% growth in earnings for the July-September quarter from the same period last year, driven...
Load More
